Qian Jiang Leaves Johns Hopkins for China
The former Wilmer Eye Institute professor has joined Zhejiang University after 24 years at the U.S. institution.
Updated on Nov. 4, 2026 in People
Qian Jiang has left Johns Hopkins University after 24 years, where he joined in 2002 and held tenured and endowed chair positions at the Wilmer Eye Institute. He has been appointed Qiushi Chair Professor at Sir Run Run Shaw Hospital, affiliated with Zhejiang University in Hangzhou.
Why it matters
The move reflects Sir Run Run Shaw Hospital's effort to strengthen its research capabilities through an international recruitment program targeting experienced researchers. It also illustrates the continued movement of senior biomedical scientists between U.S. and Chinese institutions.
Qian Jiang's record includes more than 200 scientific papers, over 19,000 citations and funding for more than 30 research projects. Johns Hopkins University ranked ninth in the 2027 U.S. News & World Report national university rankings.
The players
Qian Jiang
A researcher who directed a bioinformatics laboratory at Johns Hopkins University and has published widely on eye disease and biomedical research.
Sir Run Run Shaw Hospital
A hospital in Hangzhou affiliated with Zhejiang University that was founded in 1994 and runs an international recruitment program for researchers.
Johns Hopkins University
A private research university in Baltimore, Maryland, whose Wilmer Eye Institute Qian Jiang previously served.
The details
Qian Jiang plans to focus on eye transplantation and the development of virtual cells at Zhejiang University. He intends to use the university's clinical and multidisciplinary resources to advance early disease diagnosis, drug development and precision medicine.
Timeline
2002: Qian Jiang joins Johns Hopkins University.
October 2026: Sir Run Run Shaw Hospital announces his appointment as Qiushi Chair Professor.
Market Landscape
The appointment is a direct result of Sir Run Run Shaw Hospital's international recruitment program aimed at experienced researchers. It positions the Hangzhou hospital to compete for senior biomedical talent that has historically concentrated at U.S. universities.
For researchers and students following biomedical careers, the move signals expanding opportunities at Chinese institutions for senior scientists. Readers tracking research funding and publication trends may find the shift relevant to where future eye disease studies are conducted.
The takeaway
Senior academic moves like this one show how international hospitals are competing directly for established researchers. Tracking such appointments can offer insight into where future biomedical research leadership is forming.
Further reading
Explore more People coverage for other leadership and career moves in business and research.
Source note: This article includes information reported by VnExpress International – Latest news, business, travel and analysis from Vietnam.
